Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD

This study has been completed.
Sponsor:
Collaborator:
Shire
Information provided by:
New River Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00556296
First received: November 7, 2007
Last updated: June 20, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
Publications:
Faraone SV, Spencer TJ, Kollins SH and Glatt SJ. Moderators of Dose-Response Effects of Lisdexamfetamine Dimesylate Treatment in Children With ADHD. Journal of ADHD and Related Disorders 1(3):16-24, 2010

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):